Tag: Anemia
FDA Approves ‘Biosimilar’ Drug to Treat Certain Types of Anemia
Retacrit is biosimilar to the drugs Epogen and Procrit
IV Bevacizumab Effective for Severe HHT-Related Bleeding
Drop in RBC transfusion requirements, epistaxis severity in hereditary hemorrhagic telangiectasia
Long-Acting Erythropoiesis Agents Can Help Save Resources
Findings based upon time costs of preparation and administration per patient
High Rate of Anemia Seen After Weight-Loss Surgery
Anemia much more common among patients who did not have close follow-up with weight-loss surgeon
Immunosuppressant Response Predicts Aplastic Anemia Survival
Overall survival superior in therapy responders; shorter relapse-free survival with partial response
FeSO4 May Be Best Iron Choice in Pediatric Iron-Deficiency Anemia
Greater increase in mean hemoglobin at 12 weeks versus iron polysaccharide complex
Warm Autoimmune Hemolytic Anemia ID’d After Babesiosis
WAHA developed in six patients at two to four weeks after babesiosis diagnosis; all six patients asplenic
Delayed Clamping Reduces Anemia at 8, 12 Months of Age
Reduced risk of anemia at 8 and 12 months for infants at high risk of iron deficiency anemia
Iron Deficiency Anemia Ups Risk of Hearing Loss in U.S. Adults
After adjustment for sex, adults with IDA have increased odds of SNHL, combined hearing loss
Anemia Tied to Increased Mortality Risk Following Stroke
Higher mortality risk at multiple time points for up to one year after ischemic, hemorrhagic stroke
